THE LIAISON GROUP, LLC for NATIONAL CANNABIS ROUNDTABLE
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 14, 2023 | $65,500 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 17, 2023 | $65,500 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
Ensuring cannabis businesses have access to financial services (in former Congresses the SAFE Banking Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB | — |
| DAVID MANGONE | — |
Government Issues GOV
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB | — |
| DAVID MANGONE | — |
Budget/Appropriations BUD
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB | — |
| DAVID MANGONE | — |
Law Enforcement/Crime/Criminal Justice LAW
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including the Misdemeanor Expungement Act and the HOPE Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB | — |
| DAVID MANGONE | — |
Consumer Issues/Safety/Products CSP
Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and hemp-derived intoxicating products
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB | — |
| DAVID MANGONE New | Charlie Rangel March 2016- December 2016 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.